Asimiadou, Stiliani <br/><br/>
Protection with estradiol in developmental models of apoptotic neurodegeneration.  [electronic resource] 

 -  Annals of neurology  Aug 2005 
 - 266-76 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0364-5134 
<br/><br/><label>Standard No.: </label>10.1002/ana.20553  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Apoptosis--drug effects<br/>Bicuculline--pharmacology<br/>Blotting, Western--methods<br/>Brain--drug effects<br/>Caenorhabditis elegans Proteins--pharmacology<br/>Cell Count--methods<br/>Cells, Cultured<br/>Cerebral Cortex--cytology<br/>Disease Models, Animal<br/>Dizocilpine Maleate<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Estradiol--therapeutic use<br/>Estrogen Antagonists--pharmacology<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>GABA Antagonists--pharmacology<br/>Hypoxia--complications<br/>Immunohistochemistry--methods<br/>In Situ Nick-End Labeling--methods<br/>Membrane Potentials--drug effects<br/>Neurodegenerative Diseases--etiology<br/>Neurons--drug effects<br/>Neuroprotective Agents--therapeutic use<br/>Patch-Clamp Techniques--methods<br/>Phenobarbital<br/>Phenytoin<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-akt<br/>Rats<br/>Rats, Wistar<br/>Receptors, GABA-A<br/>Silver Staining--methods<br/>Tamoxifen--pharmacology